PellePharm Competitors and Similar CompaniesClear all
PellePharm's competitors and similar companies include Harbour Antibodies, GrayBug and Rebiotix.
 Harbour Antibodies Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies. |  Rebiotix Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. | |||
Founding Date | Founding Date 2012 | Founding Date 2006 | Founding Date 2011 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations San Francisco, US HQ | Locations Newton, US HQ | Locations Redwood City, US HQ Baltimore, US | Locations Saint Paul, US HQ |
Employees | Employees 5 | Employees 1 | Employees 4 | Employees 70 |
Funding | ||||
Latest funding round | Latest funding round $ 70m (over 7 years ago) | Latest funding round $ 3.2m (almost 13 years ago) | Latest funding round $ 80m (almost 7 years ago) | Latest funding round $ 25m (almost 12 years ago) |
Total funding raised | Total funding raised $ 81.4m | Total funding raised $ 3.2m | Total funding raised $ 128.5m | Total funding raised $ 27.8m |
For sources of this data, please see the company profile
View Company Profiles
Harbour Antibodies
HQ
Newton, US
Employees
1
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
View company
GrayBug
HQ
Redwood City, US
Employees
4
GrayBug is a biotechnology company developing technologies to treat eye diseases.
View companyRebiotix
HQ
Saint Paul, US
Employees
70
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
View company